Univar Solutions Inc., a global chemical and ingredient distributor and provider of value-added services, and Novozymes, the world leader in biological solutions, signed a new agreement to expand the partnership into the United States and Canadian food ingredients markets. The new food ingredients agreement takes effect May 1, one month after the companies announced an exclusive agreement expanding the partnership into the United States and Canadian beverage production, homecare, and industrial cleaning markets.
Univar Solutions Inc., a global chemical and ingredient distributor and provider of value-added services, and Novozymes, the world leader in biological solutions, signed an agreement, effective April 1, to expand the existing partnership into the U.S. and Canadian homecare, industrial cleaning, and beverages markets. The ongoing and expanding relationship between the two companies demonstrates a shared commitment to providing customers with a portfolio of ingredients designed to help improve product performance and enable solutions that have the potential to bring more sustainable products to the homecare, industrial cleaning and beverages markets through better performing formulations.
Novozymes, the world leader in biological solutions headquartered in Denmark, is entering the biocontrol segment of agriculture with promising enzyme-based technology – expanding beyond its current base of microbial products and innovation. The new technology – the company claims – has broad potential to control major pests that impact the agricultural industry and are responsible for billions of dollars of damages each year.
The BRAIN Group announced an expansion of its production capacities. The installation of new production facilities in both Büttelborn, near Darmstadt, Germany, by WeissBioTech GmbH (WBT) and in Cardiff, Wales, by Biocatalysts Ltd. lays the foundation for future growth.
The companies of the BRAIN Group form a closely knit network in the fields of R&D and production or as suppliers in specific markets. Drawing on the particular competencies of its subsidiaries, BRAIN brings its own innovative research results to market launch and commercializes existing products. By expanding its production capacities, BRAIN reinforces the strategic focus on its product business.
MetGen is a Finnish company headquartered in Kaarina and founded in 2008 on the core competence of genetic engineering and synthetic biology.
Now, for the first time, Novozymes’ enzymes are available online through Alibaba’s platform for industrial products, 1688.com.
“We want to be a front runner in providing biological solutions online as well as offline. By partnering with Alibaba, we will get even closer to our end-customers, address local market needs faster and explore new application opportunities,” says Thomas Videbæk, COO and Executive Vice President, Novozymes.
Royal DSM, a global science-based company active in health, nutrition and materials, headquartered in the Netherlands, will bring innovative solutions to the biofuels industry with a full portfolio offering of yeast and enzymes for starch, fiber and biomass conversions.
Novozymes launched two new enzymes for the European ethanol market. The two products (Spirizyme® 2.0 T and Spirizyme Ultra T) are part of the Spirizyme T Portfolio, an advanced suite of glucoamylase enzymes with trehalase that deliver yield enhancing activities documented to provide the highest total sugar conversion in the industry.
Novozymes launched the Spirizyme® T Portfolio, an advanced suite of glucoamylase enzymes with trehalase and other yield enhancing activities that provide the most total sugar conversion in the industry. Trehalase is an enzyme that converts trehalose, a type of sugar that cannot be fermented to ethanol, to glucose, which is easily fermentable.
Clariant’s cellulosic ethanol using sunliquid® technology can achieve price competitiveness with sugarcane ethanol pricing in Brazil. To say it is the Swiss chemical company in a note.